Title : Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma.

Pub. Date : 2013 Aug 8

PMID : 23782157






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma. ibrutinib Bruton tyrosine kinase Homo sapiens
2 In a phase 1 study, ibrutinib, a BTK inhibitor, showed antitumor activity in several types of non-Hodgkin"s lymphoma, including mantle-cell lymphoma. ibrutinib Bruton tyrosine kinase Homo sapiens